Who has invested in Thrombolex?

OrbiMed are named among the investors backing Thrombolex.

Thrombolex Funding: $50M Raised, Series A

Thrombolex funding overview

Thrombolex is based in New Britain. Thrombolex has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A. Investors on record include OrbiMed.

Thrombolex at a glance

Total raised: $50M
Latest round: Series A
Headquarters: New Britain
Notable investors: OrbiMed

Frequently asked about Thrombolex funding

How much has Thrombolex raised?: Thrombolex has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Thrombolex?: OrbiMed are named among the investors backing Thrombolex.
What was the latest Thrombolex funding round?: The most recent disclosed round is a Series A.
Where is Thrombolex based?: Thrombolex is based in New Britain.

Round data for Thrombolex is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New Britain and backer lists below.

Thrombolex Funding: $50M Raised, Series A

Thrombolex funding overview

Thrombolex at a glance

Frequently asked about Thrombolex funding

Companies related to Thrombolex (18)

Browse related funding lists (2)